MYELOSUPPRESSION
Clinical trials for MYELOSUPPRESSION explained in plain language.
Never miss a new study
Get alerted when new MYELOSUPPRESSION trials appear
Sign up with your email to follow new studies for MYELOSUPPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shields bone marrow in tough lung cancer cases
Disease control Recruiting nowThis study tests whether giving a bone marrow-protecting drug (trilaciclib) before chemotherapy (sacituzumab tirumotecan) can reduce serious side effects like low white blood cell counts in people with advanced EGFR-mutant lung cancer that no longer responds to standard targeted …
Matched conditions: MYELOSUPPRESSION
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New drug aims to shield cancer patients from chemo side effect
Disease control Recruiting nowThis study tests a drug called mecapegfilgrastim in 30 adults with lung or esophageal cancer who are getting chemotherapy and radiation. The goal is to see if it can safely prevent or reduce myelosuppression, a condition where the body makes fewer blood cells. Participants will b…
Matched conditions: MYELOSUPPRESSION
Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC